Abstract：【Objective】To investigate the relationship between estrogen level and the high incidence of biliary calculi in obese patients in Xinjiang. 【Methods】The clinical data of 118 obese patients with biliary tract stones(the observation group) were retrospectively collected, and the clinical data of 118 inpatients in the weight loss center of our hospital during the same period were selected(the control group). The levels of estradiol(E2), luteinizing hormone(LH), follicle-stimulating hormone(FSH), testosterone(T), progesterone(P) and prolactin(PRL) in 118 obese patients with biliary calculi and 118 obese patients without biliary calculi were compared and analyzed between the two groups.【Results】Compared with the control group, the hormone levels of FSH, T, P and PRL in obese men with cholelithiasis were not statistically significant. Serum LH and E2 levels were significantly higher than those of the control group, and the difference was statistically significant(P<0.05) .There was no statistically significant difference in the levels of LH, FSH, T, P and PRL between the obese premenopausal female stone patients and the control group. The serum E2 level was significantly higher than that of the control group, and the difference was statistically significant(P<0.05). Compared with the control group, the E2 level was significantly different before menopause(P< 0.04) and after menopause(P< 0.001). LH, FSH, T, P and PRL levels were not significantly different in patients with multiple calculi and single calculi, while the E2 level in patients with multiple calculi was significantly higher than those with single calculi(P<0.02). 【Conclusion】The increase of serum E2 levels in female patients with biliary tract stones before and after menopause may be related to the onset of biliary stones, and the increase of serum LH and E2 levels in male patients may be related to the onset of biliary stones.
阿扎提江·艾尼瓦尔, 阿卜杜外力·艾尔肯, 玉苏甫, 于文庆, 克力木. 雌激素水平对新疆肥胖胆道结石患者发病的影响[J]. 医学临床研究, 2021, 38(7): 1002-1004.
Azatijiang Ainiwaer, Abuduwail Erken, YU Su-fu,et al. Estrogen Levels and Receptors in the High Incidence of Biliary Calculi in Obese Patients in Xinjiang. JOURNAL OF CLINICAL RESEARCH, 2021, 38(7): 1002-1004.
[1] LI V K,PULIDO N,FAJNWAKS P, et al. Predictors of gallstone for mation after bariatric surgery:a multivariate anaiysis of risk factors comparing gastric bypass, gastric banding ,and sleeve gastretomy[J].Surg Endosc,2009,23(7):1640-1644. [2] NAHUM A, MENDEZ S, NORBERTO C, et al. Metabolic Syndrone as a risk factor for gallstone disease [J].World J Gastroenterol,2005,11(11):1635-1657. [3] PORTINCASA P, WANG D Q. Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol:where are we for cholesterol gallstone formation[J].Hepatology,2012,55(5):1313-1316. [4] HALLDESTAM I, ENELL E-L, KULLMAN E, et al. Development of symptoms and complications in individuals with asymptomatic gallstones [J].Br J Surg,2004,91(6):734-738. [5] ERLINGER S. Gallstones in obesity and weight loss[J].Eur J Gastroenterol Hepatol,2000,12(12):1347-1352. [6] 杜小娟.胆囊切除与代谢综合征及其危险因素的相关性分析[J].医学临床研究, 2014,31(7):1329-1330. [7] WANG H H, LIU M, CLEGG D J, et al. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation[J].Biochim Biophys Acta,2009,1791(11):1037-1047. [8] SIERON D, CZERNY B, SIERON-STOLTNY K, et al. The effect of chronic estrogen application on bile and gallstone composition in women with cholelithiasis[J].Minerva Endocrinol,2016,41(1):19-27. [9] WANG S, WANG Y, XU J, et al. Is the oral contraceptive or hormone replacement therapy a risk factor for cholelithiasis:A systematic review and meta-analysis[J].Medicine(Baltimore),2017,96(14):e6556. [10] KLINE L, KARPINSKI E. Gallbladder motility and the sex of the guinea pig[J].Physiol Rep,2016 ,4(12) :e12843. [11] RICCETTI L, De PASCALI F, GILIOLI L, et al. Human LH and hCG stimulate differently the early signalling pathways but result in equal testosterone synthesis in mouse Leydig cells in vitro[J].Reprod Biol Endocrinol,2017,15(1):2. [12] COLLONGUES N, PATTE-MENSAH C, De SEZE J, et al. Testosterone and estrogen in multiple sclerosis:from pathophysiology to therapeutics[J].Expert Rev Neurother,2018,18(6):515-522.
2021, Vol. 38 
